| Related Articles |
Compliance to clinical pathways in the management of suspected pulmonary embolus: are there cost implications?
Intern Med J. 2017 Apr;47(4):458-461
Authors: Rehman A, Yelf E, Pearson J, Yeo W
Abstract
This study investigated the cost implications of poor compliance to established guidelines for management of suspected pulmonary embolism (PE) in two NSW public hospitals. A retrospective audit showed that the prevalence of PE overall was 9.9% (4.3% in the low-risk groups) in 436 patients. An estimated total of $32 454 (14%) was spent on unnecessary tests.
PMID: 28401718 [PubMed - in process]